Aarhus University Seal

Dansk

You are here: » Morten Høyer

About Aarhus University

Morten Høyer

Clinical Professor, MD, PhD, Professor, MD, PhD

Profile photoMorten Høyer
Department of Clinical Medicine - The Department of Oncology
Postal address:
Nørrebrogade 44
8000
Aarhus C
Denmark
Email: morten.hoyer@oncology.au.dk
Mobile: +4523282823

Year of birth

1959

Educations

1997Specialist in Oncology , Aarhus University Hospital, Denmark
1985MD, Health, Aarhus Universits Hospital, Denmark

Academic degrees

1994PHD. in Medicine, Aarhus University, Denmark

Research areas

Biological, technical and clinical trials with Stereotactic Body Radiotherapy of brain, lung and liver tumours.
Radiation therapy of bladder and prostate cancer.
Radiotherapy for childhood cancer.
Radiation induced morbidity.
Particle radiotherapy.

Present position

2016-Professor, chief consultant, Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark

Previous positions

2012-2016Professor, Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
2004-2012Associate professor, Department of Oncology, Aarhus University Hospital, Denmark
1999-2016Consultant, Department of Oncology, Aarhus University Hospital, Denmark
1997-1999Junior consultant, Department of Oncology, Aarhus University Hospital, Denmark
1996-1997Senior registrar, Department of Oncology, Herlev Hospital, Denmark
1993-1996Senior registrar, Department of Oncology, Aarhus University Hospital, Denmark
1990-1993Scientific assistant, Department for Experiomental Clinical Oncology, Denmark

Publications and præsentations

Publications: 138 scientific articles, 5 book chapters, H-index: 30, number of citations: 4600, scientific meeting presentations (oral): 100.

Board memberships

Clinical Committee of European Society for Therapeutic Radiology and Oncology (ESTRO)
Advisory Committee on Radiation Oncology Practice (ACROP)
Secretary of Danish Multidisciplinary Uro-oncology Group and Danish Multidisciplinary Prostatic Cancer Group
Member of the Scandinavian Prostatic Cancer Group (SPCG) steering committee (2001-2011)
Member of the Nordic Stereotactic Body Radiotherapy Group
Member of the joint ASTRO-ESTRO-CARO-TROG Consensus Group on Palliative
Radiotherapy
Member of IAEA Consultant Committee on Stereotactic Radiotherapy
Member of the advisory board of Acta Oncologica
Chairman of The Danish Cancer Research Foundation (Dansk Kræftforskningsfond)

Organization of clinical trials

National coordinator and member of steering committee for the nordic SPCG-7, SPCG-14 experiments and the Hypo-Prost study
National coordinator and investigator in experiments with chemotherapy for urological cancer
Trial secretary of the IAEA study on transarterial chemoembolization (TACE) versus stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma

Supervision

Supervisor for 12 PHD.-students at the Faculty of Health Sciences, Aarhus University, Denmark

Evaluations

23 PhD. thesis
2 professor evaluations

Awards and grants

William Nielsens Fonundation Award (2012)
Professor Carl Krebs' Fødselsdagslegat (æreslegat) (2007)
Kaj Bunch-Jensen and Allis Bunch-Jensen Foundation Award (2013)

Major research grants

Danish Cancer Society (2002, 2006, 2009, 2012 and 2015)
Maersk McKinney Møller og Hustru Chastine Møllers Fond til Almene Formaal (2008, 2009 and 2010)
Dansk Kræftforskningsfond (2007)
Nordic Cancer Union (2011)

External grant reviewer

Henry Nielsens Fond (2013)
Dansk Cancerforskningsfond (2008-2011)

Organizer of Meetings

European Society of Therapeutic Radiology and Oncology ESTRO 35, (Torino 2016)
European Cancer Organisation ECCO (Vienna 2015)
3rd ESTRO Forum (Barcelona 2015)
EPI2K14 (Aarhus 2014)
Acta Oncologica Symposia in Biology-Guided Adaptive Radiation Therapy (Aarhus 2012)
Acta Oncologica Symposia in Particle Therapy (Uppsala 2011)
Acta Oncologica Symposia in Biology-Guided Adaptive Radiation Therapy (Aarhus 2010)
Acta Oncologica Symposia in Image Guided Radiotherapy (Aarhus 2008)
Acta Oncologica Symposia in Stereotactic Body Radiation Therapy (Copenhagen 2006)
4th Nordic Conference in Radiation Oncology (Aarhus 2000)

Memberships

Den almindelige danske Lægeforening og Foreningen af speciallæger
Dansk Selskab for Klinisk Onkologi
European Society for Therapeutic Radiology and Oncology

Publications

Proton therapy planning and image-guidance strategies within a randomized controlled trial for high-risk prostate cancer

Tilbæk, S., Muren, L. P., Vestergaard, A., Stolarczyk, L., Rønde, H. S., Johansen, T. S., Søndergaard, J., Høyer, M., Alsner, J., Bentzen, L. N. & Petersen, S. E., Jul 2023, In: Clinical and Translational Radiation Oncology. 41, 7 p., 100632.

Intrafraction tumor motion monitoring and dose reconstruction for liver pencil beam scanning proton therapy

Nankali, S., Worm, E. S., Thomsen, J. B., Stick, L. B., Bertholet, J., Høyer, M., Weber, B., Mortensen, H. R. & Poulsen, P. R., Mar 2023, In: Frontiers in Oncology. 13, 11 p., 1112481.

European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making

Andratschke, N., Willmann, J., Appelt, A. L., Alyamani, N., Balermpas, P., Baumert, B. G., Hurkmans, C., Høyer, M., Langendijk, J. A., Kaidar-Person, O., van der Linden, Y., Meattini, I., Niyazi, M., Reynaert, N., De Ruysscher, D., Tanadini-Lang, S., Hoskin, P., Poortmans, P. & Nieder, C., Oct 2022, In: The Lancet Oncology. 23, 10, p. e469-e478 10 p.

A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group

Barcellini, A., Massaro, M., Dal Mas, F., Langendijk, J. A., Høyer, M., Calugaru, V., Haustermans, K., Timmermann, B., Thariat, J., Scartoni, D., Vennarini, S., Georg, P. & Orlandi, E., May 2022, In: Clinical and Translational Radiation Oncology. 34, p. 1-6 6 p.

Current practice in proton therapy delivery in adult cancer patients across Europe

Tambas, M., van der Laan, H. P., Steenbakkers, R. J. H. M., Doyen, J., Timmermann, B., Orlandi, E., Hoyer, M., Haustermans, K., Georg, P., Burnet, N. G., Gregoire, V., Calugaru, V., Troost, E. G. C., Hoebers, F., Calvo, F. A., Widder, J., Eberle, F., van Vulpen, M., Maingon, P., Skóra, T., & 4 othersWeber, D. C., Bergfeldt, K., Kubes, J. & Langendijk, J. A., Feb 2022, In: Radiotherapy and Oncology. 167, p. 7-13 7 p.

No time to die - BiGART is back. The 20th Acta Oncologica Symposium - BIGART 2021

Høyer, M., Grau, C. & Overgaard, J., Feb 2022, In: Acta Oncologica. 61, 2, p. 117-119 3 p.

Proton therapy for early breast cancer patients in the DBCG proton trial: planning, adaptation, and clinical experience from the first 43 patients

Jensen, M. F., Stick, L. B., Hoyer, M., Kronborg, C. J. S., Lorenzen, E. L., Mortensen, H. R., Nystrom, P. W., Petersen, S. E., Randers, P., Thai, L. M. H., Yates, E. S. & Offersen, B. V., Feb 2022, In: Acta Oncologica. 61, 2, p. 223-230 8 p.

Spot-scanning proton therapy for targets with adjacent cardiac implantable electronic devices – Strategies for breast and head & neck cancer

Stick, L. B., Lægdsmand, P. M. T., Bjerre, H. L., Høyer, M., Jensen, K., Jensen, M. F., Kronborg, M. B., Offersen, B. V. & Kronborg, C. J. S., Jan 2022, In: Physics and Imaging in Radiation Oncology. 21, p. 66-71 6 p.

A phase I/II study of acute and late physician assessed and patient-reported morbidity following whole pelvic radiation in high-risk prostate cancer patients

Petersen, S. E., Thorsen, L. B., Hansen, S., Petersen, P. M., Lindberg, H., Moe, M., Petersen, J. B., Muren, L. P., Høyer, M. & Bentzen, L., 2022, In: Acta Oncologica. 61, 2, p. 179-184 6 p.

Clinical outcomes after stereotactic ablative radiotherapy in locally advanced cholangiocarcinoma

Thuehøj, A. U., Andersen, N. C., Worm, E. S., Høyer, M., Tabaksblat, E. M., Weber, B. & Mortensen, H. R., 2022, In: Acta Oncologica. 61, 2, p. 197-201 5 p.

Associations between patient-reported outcomes and radiation dose in patients treated with radiation therapy for primary brain tumours

Haldbo-Classen, L., Amidi, A., Wu, L. M., Lukacova, S., Oettingen, G., Lassen-Ramshad, Y., Zachariae, R., Kallehauge, J. F. & Høyer, M., Nov 2021, In: Clinical and Translational Radiation Oncology. 31, p. 86-92 7 p.

Delineation atlas of the Circle of Willis and the large intracranial arteries for evaluation of doses to neurovascular structures in pediatric brain tumor patients treated with radiation therapy

Toussaint, L., Peters, S., Mikkelsen, R., Karabegovic, S., Bäumer, C., Muren, L. P., Tram-Henriksen, L., Høyer, M., Lassen-Ramshad, Y. & Timmermann, B., Nov 2021, In: Acta Oncologica. 60, 11, p. 1392-1398 7 p.

Real-time dose-guidance in radiotherapy: Proof of principle

Muurholm, C. G., Ravkilde, T., Skouboe, S., Worm, E., Hansen, R., Høyer, M., Keall, P. J. & Poulsen, P. R., Nov 2021, In: Radiotherapy and Oncology. 164, p. 175-182 8 p.

Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy?

Sørensen, B. S., Pawelke, J., Bauer, J., Burnet, N. G., Dasu, A., Høyer, M., Karger, C. P., Krause, M., Schwarz, M., Underwood, T. S. A., Wagenaar, D., Whitfield, G. A. & Lühr, A., Oct 2021, In: Radiotherapy and Oncology. 163, p. 177-184 8 p.

Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [18F]FDGal PET/CT

Sørensen, M., Fode, M. M., Petersen, J. B., Holt, M. I. & Høyer, M., Oct 2021, In: Radiation Oncology. 16, 1, 7 p., 192.

Uniform versus non-uniform dose prescription for proton stereotactic body radiotherapy of liver tumors investigated by extensive motion-including treatment simulations

Worm, E. S., Hansen, R., Hoyer, M., Weber, B., Mortensen, H. & Poulsen, P. R., Oct 2021, In: Physics in Medicine and Biology. 66, 20, 205009.

Risk of cardiac implantable electronic device malfunctioning during pencil beam proton scanning in an in vitro setting

Bjerre, H. L., Kronborg, M. B., Nielsen, J. C., Høyer, M., Jensen, M. F., Zaremba, T., Lægdsmand, P. M. T., Søndergaard, C. S., Nyström, H. & Kronborg, C. J. S., Sept 2021, In: International Journal of Radiation Oncology, Biology, Physics. 111, 1, p. 186-195 10 p.

Androgen Deprivation Therapy Combined With Particle Therapy for Prostate Cancer: A Systematic Review

Petersen, S. E. & Høyer, M., Jun 2021, In: Frontiers in Oncology. 11, 695647.

Response to: 'Comments on "Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma" by Toussaint, et al.: Prior similar field arrangement work and a need for variable RBE Use'

Toussaint, L., Indelicato, D. J., Muren, L. P., Li, Z., Lassen, Y. A., Kirby, K., Pedro, C., Mikkelsen, R., Di Pinto, M., Høyer, M. & Stokkevåg, C. H., May 2021, In: Radiotherapy & Oncology. 158, p. 330-331 2 p.

Research in radiation oncology and the Covid-19 pandemic

Høyer, M. & Grau, C., Mar 2021, In: Acta Oncologica. 60, 3, p. 275-276 2 p.

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial

Fransson, P., Nilsson, P., Gunnlaugsson, A., Beckman, L., Tavelin, B., Norman, D., Thellenberg-Karlsson, C., Hoyer, M., Lagerlund, M., Kindblom, J., Ginman, C., Johansson, B., Björnlinger, K., Seke, M., Agrup, M., Zackrisson, B., Kjellén, E., Franzén, L. & Widmark, A., Feb 2021, In: The Lancet Oncology. 22, 2, p. 235-245

A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients

Brandal, P., Bergfeldt, K., Aggerholm-Pedersen, N., Backstrom, G., Kerna, I., Gubanski, M., Bjornlinger, K., Evensen, M. E., Kuddu, M., Pettersson, E., Brydoy, M., Hellebust, T. P., Dale, E., Valdman, A., Weber, L. & Hoyer, M., 2 Oct 2020, In: Acta Oncologica. 59, 10, p. 1157-1163 7 p.

A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients

Brandal, P., Bergfeldt, K., Aggerholm-Pedersen, N., Bäckström, G., Kerna, I., Gubanski, M., Björnlinger, K., Evensen, M. E., Kuddu, M., Pettersson, E., Brydøy, M., Hellebust, T. P., Dale, E., Valdman, A., Weber, L. & Høyer, M., Oct 2020, In: Acta Oncologica. 59, 10, p. 1157-1163 7 p.

Is there a Nordic solution for the ‘proton-problem’?

Bergfeldt, K., Nystrom, H., Witt Nystrom, P. & Høyer, M., Oct 2020, In: Acta Oncologica. 59, 10, p. 1137-1138 2 p.

Metastasis directed treatment of brain metastases from colorectal cancer - a Danish population-based cohort study

Boysen, A. K., Ording, A. G., Astradsson, A., Høyer, M. & Spindler, K-L., Sept 2020, In: Acta Oncologica. 59, 9, p. 1118-1122 5 p.

Cognitive impairment following radiation to hippocampus and other brain structures in adults with primary brain tumours

Haldbo-Classen, L., Amidi, A., Lukacova, S., Wu, L. M., Oettingen, G. V., Lassen-Ramshad, Y., Zachariae, R., Kallehauge, J. F. & Høyer, M., Jul 2020, In: Radiotherapy and Oncology. 148, p. 1-7 7 p.

Isotoxic dose prescription level strategies for stereotactic liver radiotherapy: the price of dose uniformity

Hansen, A. T., Poulsen, P. R., Hoyer, M. & Worm, E. S., May 2020, In: Acta Oncologica. 59, 5, p. 558-564 7 p.

Nonsurgical Salvage Local Therapies for Radiorecurrent Prostate Cancer: A Systematic Review and Meta-analysis

Ingrosso, G., Becherini, C., Lancia, A., Caini, S., Ost, P., Francolini, G., Høyer, M., Bottero, M., Bossi, A., Zilli, T., Scartoni, D., Livi, L., Santoni, R., Giacomelli, I. & Detti, B., Apr 2020, In: European urology oncology. 3, 2, p. 183-197 15 p.

Simulated multileaf collimator tracking for stereotactic liver radiotherapy guided by kilovoltage intrafraction monitoring: Dosimetric gain and target overdose trends

Poulsen, P. R., Murtaza, G., Worm, E. S., Ravkilde, T., O'Brien, R., Grau, C., Høyer, M. & Keall, P., Mar 2020, In: Radiotherapy and Oncology. 144, p. 93-100 8 p.

Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma

Toussaint, L., Indelicato, D. J., Muren, L. P., Li, Z., Lassen-Ramshad, Y., Kirby, K., Pedro, C., Mikkelsen, R., Di Pinto, M., Høyer, M. & Stokkevåg, C. H., Jan 2020, In: Radiotherapy and Oncology. 142, p. 140-146 7 p.

Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document

Lievens, Y., Guckenberger, M., Gomez, D., Hoyer, M., Iyengar, P., Kindts, I., Méndez Romero, A., Nevens, D., Palma, D., Park, C., Ricardi, U., Scorsetti, M., Yu, J. & Woodward, W. A., 2020, In: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 148, p. 157-166 10 p.

Radionecrosis and cellular changes in small volume stereotactic brain radiosurgery in a porcine model

Zaer, H., GLUD, AN., Schneider, B. M., Lukacova, S., Vang Hansen, K., Adler, J. R., Høyer, M., Jensen, M. B., Hansen, R., Hoffmann, L., Worm, E. S., Sørensen, J. C. H. & Orlowski, D., 2020, In: Scientific Reports. 10, 1, 12 p., 16223.

Evaluating the neuromodulative effects of radiosurgery on the brain tissue

Zaer, H., GLUD, AN., M. Schneider, B., Lukacova, S., Hansen, K. V., R. Adler, J., Høyer, M., Jensen, M. B., Hoffman, L., Hansen, R., Worm, E. S., Sørensen, J. C. H. & Orlowski, D., 3 Oct 2019.

BIGART 2019 - adapting to the future

Overgaard, J., Muren, L. P., Høyer, M. & Grau, C., Oct 2019, In: Acta Oncologica. 58, 10, p. 1323-1327 5 p.

First clinical real-time motion-including tumor dose reconstruction during radiotherapy delivery

Skouboe, S., Ravkilde, T., Bertholet, J., Hansen, R., Worm, E. S., Muurholm, C. G., Weber, B., Høyer, M. & Poulsen, P. R., Oct 2019, In: Radiotherapy and Oncology. 139, p. 66-71 6 p.

Radiation doses to brain substructures associated with cognition in radiotherapy of pediatric brain tumors

Toussaint, L., Indelicato, D. J., Stokkevåg, C. H., Lassen, Y. A., Pedro, C., Mikkelsen, R., Di Pinto, M., Li, Z., Flampouri, S., Vestergaard, A., Petersen, J. B. B., Schrøder, H., Høyer, M. & Muren, L. P., Oct 2019, In: Acta Oncologica. 58, 10, p. 1457-1462 6 p.

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Widmark, A., Gunnlaugsson, A., Beckman, L., Thellenberg-Karlsson, C., Hoyer, M., Lagerlund, M., Kindblom, J., Ginman, C., Johansson, B., Björnlinger, K., Seke, M., Agrup, M., Fransson, P., Tavelin, B., Norman, D., Zackrisson, B., Anderson, H., Kjellén, E., Franzén, L. & Nilsson, P., 3 Aug 2019, In: The Lancet. 394, 10196, p. 385-395 11 p.

Patient specific outcomes of charged particle therapy for hepatocellular carcinoma – A systematic review and quantitative analysis

Spychalski, P., Kobiela, J., Antoszewska, M., Błażyńska-Spychalska, A., Jereczek-Fossa, B. A. & Høyer, M., Mar 2019, In: Radiotherapy and Oncology. 132, p. 127-134 8 p.

Long-term cognitive dysfunction after radiation therapy for primary brain tumors

Haldbo-Classen, L., Amidi, A., Wu, L. M., Lukacova, S., Oettingen, G. V., Gottrup, H., Zachariae, R. & Høyer, M., 2019, In: Acta Oncologica. 58, 5, p. 745-752 8 p.

Oligorecurrent prostate cancer limited to lymph nodes:getting our ducks in a row: Nodal oligorecurrent prostate cancer

Fodor, A., Lancia, A., Ceci, F., Picchio, M., Høyer, M., Jereczek-Fossa, B. A., Ost, P., Castellucci, P., Incerti, E., Di Muzio, N. & Ingrosso, G., 2019, In: World Journal of Urology. 37, 12, p. 2607-2613 7 p.

Protonbehandling

Mortensen, H. R., Høyer, M. & Grau, C., 2019, In: Ugeskrift for Læger. 181, 20, V04190243.

Simulated real-time dose reconstruction for moving tumors in stereotactic liver radiotherapy

Skouboe, S., Poulsen, P. R., Muurholm, C. G., Worm, E., Hansen, R., Høyer, M. & Ravkilde, T., 2019, In: Medical Physics. 46, 11, p. 4738-4748 11 p.

Stereotactic body radiation therapy for early-stage hepatocellular carcinoma: a systematic review on outcome

Dobrzycka, M., Spychalski, P., Rostkowska, O., Wilczyński, M., Kobiela, P., Grąt, M., Dell’Acqua, V., Høyer, M. & Jereczek-Fossa, B. A., 2019, In: Acta Oncologica. 58, 12, p. 1706-1713 8 p.

Metastasis directed therapy for liver and lung metastases from colorectal cancer - A population based study

Boysen, A. K., Spindler, K-L. G., Høyer, M., Mortensen, F. V., Christensen, T. D., Kormendine Farkas, D. & Ording, A. G., 15 Dec 2018, In: International Journal of Cancer. 143, 12, p. 3218-3226 9 p.

Validation of fast motion-including dose reconstruction for proton scanning therapy in the liver

Colvill, E., Petersen, J. B. B., Hansen, R., Worm, E., Skouboe, S., Høyer, M. & Poulsen, P. R., 20 Nov 2018, In: Physics in Medicine and Biology. 63, 22, 9 p., 225021.

Limited post-chemotherapy retroperitoneal resection of residual tumour in non-seminomatous testicular cancer: complications, outcome and quality of life

Schmidt, A. H., Høyer, M., Jensen, B. F. S. & Agerbaek, M., Aug 2018, In: Acta Oncologica. 57, 8, p. 1084-1093 10 p.

Geometric and dosimetric comparison of four intrafraction motion adaptation strategies for stereotactic liver radiotherapy

Nankali, S., Worm, E. S., Hansen, R., Weber, B., Høyer, M., Zirak, A. & Poulsen, P. R., 16 Jul 2018, In: Physics in Medicine and Biology. 63, 14, 12 p., 145010.

Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus

work package 1 of the taskforce “European Particle Therapy Network” of ESTRO, 1 Jul 2018, In: Radiotherapy & Oncology. 128, 1, p. 26-36 11 p.

The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology

“European Particle Therapy Network” of ESTRO, Jul 2018, In: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 128, 1, p. 37-43 7 p.

A Prospective Cohort Study of Gated Stereotactic Liver Radiation Therapy Using Continuous Internal Electromagnetic Motion Monitoring

Worm, E. S., Høyer, M., Hansen, R., Larsen, L. P., Weber, B., Grau, C. & Poulsen, P. R., 1 Jun 2018, In: International Journal of Radiation Oncology, Biology, Physics. 101, 2, p. 366-375 10 p.

Inter-institutional analysis demonstrates the importance of lower than previously anticipated dose regions to prevent late rectal bleeding following prostate radiotherapy

Thor, M., Jackson, A., Zelefsky, M. J., Steineck, G., Karlsdòttir, A., Høyer, M., Liu, M., Nasser, N. J., Petersen, S. E., Moiseenko, V. & Deasy, J. O., Apr 2018, In: Radiotherapy & Oncology. 127, 1, p. 88-95 8 p.

Automatic online and real-time tumour motion monitoring during stereotactic liver treatments on a conventional linac by combined optical and sparse monoscopic imaging with kilovoltage x-rays (COSMIK)

Bertholet, J., Toftegaard, J., Hansen, R., Worm, E. S., Wan, H., Parikh, P. J., Weber, B., Hoyer, M. & Poulsen, P. R., 7 Mar 2018, In: Physics in Medicine and Biology. 63, 5, 055012.

Long-term urodynamic findings following radical prostatectomy and salvage radiotherapy

Ervandian, M., Djurhuus, J. C., Høyer, M., Graugaard-Jensen, C. & Borre, M., Feb 2018, In: Scandinavian Journal of Urology. 52, 1, p. 20-26 7 p.

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies

Schaub, S. K., Hartvigson, P. E., Lock, M. I., Høyer, M., Brunner, T. B., Cardenes, H. R., Dawson, L. A., Kim, E. Y., Mayr, N. A., Lo, S. S. & Apisarnthanarax, S., 1 Jan 2018, In: Technology in Cancer Research and Treatment. 17, 19 p., 1533033818790217.

Spatial rectal dose/volume metrics predict patient-reported gastro-intestinal symptoms after radiotherapy for prostate cancer

Casares-Magaz, O., Muren, L. P., Moiseenko, V., Petersen, S. E., Pettersson, N. J., Høyer, M., Deasy, J. O. & Thor, M., 2 Nov 2017, In: Acta Oncologica. 56, 11, p. 1507-1513 7 p.

A phase I study on stereotactic body radiotherapy of liver metastases based on functional treatment planning using positron emission tomography with 2-[(18)F]fluoro-2-deoxy-d-galactose

Fode, M. M., Bak-Fredslund, K., Petersen, J. B., Worm, E., Sørensen, M. & Høyer, M., Nov 2017, In: Acta Oncologica. 56, 11, p. 1614-1620 7 p.

Rethink radiotherapy - BIGART 2017

Grau, C., Høyer, M., Poulsen, P. R., Muren, L. P., Korreman, S. S., Tanderup, K., Lindegaard, J. C., Alsner, J. & Overgaard, J., Nov 2017, In: Acta Oncologica. 56, 11, p. 1341-1352 12 p.

Validation of genetic predictors of late radiation-induced morbidity in prostate cancer patients

Schack, L. M. H., Petersen, S. E., Nielsen, S., Lundby, L., Høyer, M., Bentzen, L., Overgaard, J., Andreassen, C. N. & Alsner, J., Nov 2017, In: Acta Oncologica. 56, 11, p. 1514-1521 8 p.

Re-irradiation with stereotactic body radiation therapy (SBRT)

Høyer, M., 1 Sept 2017, In: Chinese clinical oncology. 6, Suppl 2, 9 p., S15.

Simultaneous acquisition of 4D ultrasound and wireless electromagnetic tracking for in-vivo accuracy validation

Ipsen, S., Bruder, R., Worm, E. S., Hansen, R., Poulsen, P. R., Høyer, M. & Schweikard, A., 1 Sept 2017, In: Current Directions in Biomedical Engineering. 3, 2, p. 75-78 4 p.

Radiation therapy for liver metastases: Clinical data

Høyer, M., 2 Jul 2017, Radiation Therapy for Liver Tumors: Fundamentals and Clinical Practice. Springer International Publishing AG, p. 245-256 12 p.

ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer

Guckenberger, M., Andratschke, N., Dieckmann, K., Hoogeman, M. S., Hoyer, M., Hurkmans, C., Tanadini-Lang, S., Lartigau, E., Romero, A. M., Senan, S. & Verellen, D., Jul 2017, In: Radiotherapy & Oncology. 124, 1, p. 11-17 7 p.

Cone beam CT-based set-up strategies with and without rotational correction for stereotactic body radiation therapy in the liver

Bertholet, J., Worm, E., Høyer, M. & Poulsen, P., Jun 2017, In: Acta Oncologica. 56, 6, p. 860-866 7 p.

Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease

Tanadini-Lang, S., Rieber, J., Filippi, A. R., Fode, M. M., Streblow, J., Adebahr, S., Andratschke, N., Blanck, O., Boda-Heggemann, J., Duma, M., Eble, M. J., Ernst, I., Flentje, M., Gerum, S., Hass, P., Henkenberens, C., Hildebrandt, G., Imhoff, D., Kahl, H., Klass, N. D., & 10 othersKrempien, R., Lohaus, F., Petersen, C., Schrade, E., Wendt, T. G., Wittig, A., Høyer, M., Ricardi, U., Sterzing, F. & Guckenberger, M., May 2017, In: Radiotherapy & Oncology. 123, 2, p. 182-188 7 p.

Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review

Kroeze, S. G. C., Fritz, C., Hoyer, M., Lo, S. S., Ricardi, U., Sahgal, A., Stahel, R., Stuppf, R. & Guckenberger, M., Feb 2017, In: Cancer Treatment Reviews. 53, p. 25-37 13 p.

2-[18F]fluoro-2-deoxy-d-galactose positron emission tomography guided functional treatment planning of stereotactic body radiotherapy of liver tumours

Fode, M. M., Petersen, J. B. B., Sørensen, M., Holt, M. I., Keiding, S. & Høyer, M., Jan 2017, In: Physics and Imaging in Radiation Oncology. 1, p. 28-33 6 p.

Late urinary morbidity and quality of life after radical prostatectomy and salvage radiotherapy for prostate cancer

Ervandian, M., Hoyer, M., Petersen, S. E., Sengelov, L., Hansen, S., Kempel, M. M., Petersen, P. M. & Borre, M., 2017, In: Scandinavian Journal of Urology and Nephrology. 51, 6, p. 457-463 7 p.

The prognostic value of sidedness of the primary tumour after local treatment for oligometastatic colorectal cancer - a Danish population based study

Boysen, A. K., Spindler, K-L. G., Høyer, M., Christensen, T. D. & Ording, A. G., 2017.

What does large randomized trials tell us about the fractionation sensitivity of prostate cancer?

Hoyer, M., 2017, MICRO-MINI & NANO-DOSIMETRY & INNOVATIVE TECHNOLOGIES IN RADIATION THERAPY (MMND&ITRO2016). Baldock, C., Rozenfeld, A. & Metcalfe, P. (eds.). IOP Publishing, Vol. 777. 4 p. (Journal of Physics Conference Series; No. 1, Vol. 777).

Fiducial marker guided stereotactic liver radiotherapy: Is a time delay between marker implantation and planning CT needed?

Worm, E. S., Bertholet, J., Høyer, M., Fledelius, W., Hansen, A. T., Larsen, L. P., Nielsen, J. E. & Poulsen, P. R., Oct 2016, In: Radiotherapy & Oncology. 121, 1, p. 75-78 4 p.

Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7

Fosså, S. D., Wiklund, F., Klepp, O., Angelsen, A., Solberg, A., Damber, J-E., Hoyer, M., Widmark, A. & The Scandinavian Prostate Cancer Group-7 Investigators, Oct 2016, In: European Urology. 70, 4, p. 684-691 8 p.

A biological modeling based comparison of two strategies for adaptive radiotherapy of urinary bladder cancer

Lutkenhaus, L. J., Vestergaard, A., Bel, A., Høyer, M., Hulshof, M. C. C. M., van Leeuwen, C. M., Casares Magaz, O., Petersen, J. B., Søndergaard, J. & Muren, L. P., Aug 2016, In: Acta Oncologica. 55, 8, p. 1009-15 7 p.

Metabolic liver function after stereotactic body radiation therapy for hepatocellular carcinoma

Dreher, C., Høyer, K. I., Fode, M. M., Habermehl, D., Combs, S. E. & Høyer, M., Jul 2016, In: Acta Oncologica. 55, 7, p. 886-891 6 p.

Time-Resolved Intrafraction Target Translations and Rotations During Stereotactic Liver Radiation Therapy: Implications for Marker-based Localization Accuracy

Bertholet, J., Worm, E. S., Fledelius, W., Høyer, M. & Poulsen, P. R., 1 Jun 2016, In: International Journal of Radiation Oncology, Biology, Physics. 95, 2, p. 802-9 8 p.

198PD: Nomogram for predicting overall survival after stereotactic body radiotherapy for pulmonary metastases: Development and external validation

Guckenberger, M., Lang, S., Hoyer, M., Fode, M. M., Rieber, J. & Sterzing, F., Apr 2016, In: Journal of Thoracic Oncology. 11, 4 Suppl, p. S143

Urinary bladder dose-response relationships for patient-reported genitourinary morbidity domains following prostate cancer radiotherapy

Thor, M., Olsson, C., Oh, J. H., Petersen, S. E., Alsadius, D., Bentzen, L., Pettersson, N., Muren, L. P., Høyer, M., Steineck, G. & Deasy, J. O., Apr 2016, In: Radiotherapy & Oncology. 119, 1, p. 117-22 6 p.

A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)

Siva, S., Kron, T., Bressel, M., Haas, M., Mai, T., Vinod, S., Sasso, G., Wong, W., Le, H., Eade, T., Hardcastle, N., Chesson, B., Pham, D., Høyer, M., Montgomery, R. & Ball, D., 4 Mar 2016, In: B M C Cancer. 16, 1, 8 p., 183.

The potential of MRI-guided online adaptive re-optimisation in radiotherapy of urinary bladder cancer

Vestergaard, A., Hafeez, S., Muren, L., Nill, S., Høyer, M., Hansen, V. N., Grønborg, C., Pedersen, E. M., Petersen, J. B., Huddart, R. & Oelfke, U., Jan 2016, In: Radiotherapy & Oncology. 118, 1, p. 154-159 6 p.

A biological modeling based comparison of two strategies for adaptive radiotherapy of bladder cancer

Lutkenhaus, L. J., Vestergaard, A., Bel, A., Høyer, M., Hulshof, M. C. C. H., van Leeuwen, C. M., Casares Magaz, O., Petersen, J. B. B., Søndergaard, J. & Muren, L., 2016.

Biology-guided adaptive radiotherapy (BiGART) is progressing towards clinical reality

Grau, C., Overgaard, J., Høyer, M., Tanderup, K., Lindegaard, J. C. & Muren, L. P., Oct 2015, In: Acta Oncologica. 54, 9, p. 1245-50 6 p.

Intra-fractional bladder motion and margins in adaptive radiotherapy for urinary bladder cancer

Grønborg, C., Vestergaard, A., Høyer, M., Söhn, M., Pedersen, E. M., Petersen, J. B., Agerbæk, M. & Muren, L. P., Oct 2015, In: Acta Oncologica. 54, 9, p. 1461-6 6 p.

Respiratory gating based on internal electromagnetic motion monitoring during stereotactic liver radiation therapy: First results

Poulsen, P. R., Worm, E. S., Hansen, R., Larsen, L. P. S., Grau, C. & Høyer, M., Oct 2015, In: Acta Oncologica. 54, 9, p. 1445-52 8 p.

Salvage radiation therapy following radical prostatectomy. A national Danish study

Ervandian, M., Høyer, M., Petersen, S. E., Sengeløv, L., Hansen, S., Holmberg, M., Sveistrup, J., Meidahl Petersen, P. & Borre, M., 23 Sept 2015, In: Acta Oncologica. p. 1-6 6 p.

An image-based method to quantify biomechanical properties of the rectum in radiotherapy of prostate cancer

Casares-Magaz, O., Thor, M., Liao, D., Frøkjær, J. B., Kræmer, P., Krogh, K., Drewes, A. M., Gregersen, H., Moiseenko, V., Høyer, M. & Muren, L. P., Sept 2015, In: Acta Oncologica. 54, 9, p. 1335-42 8 p.

The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell types

Sørensen, B. S., Knudsen, A. B., Wittrup, C. F., Nielsen, S., Aggerholm-Pedersen, N., Busk, M., Horsman, M., Høyer, M., Bouchelouche, P. N., Overgaard, J. & Alsner, J., Sept 2015, In: Radiotherapy & Oncology. 116, 3, p. 346-51 6 p.

The evolution of radiotherapy techniques in the management of prostate cancer

Høyer, M., Muren, L. P. & Glimelius, B., Jun 2015, In: Acta Oncologica. 54, 6, p. 821-4 4 p.

Normal tissue sparing in a Phase II trial of daily adaptive plan selection in radiotherapy for urinary bladder cancer

Vestergaard, A., Muren, L., Lindberg, H., Jakobsen, K. L., Petersen, J. B. B., Elstrøm, U. V. & Høyer, M., Apr 2015, In: Radiotherapy & Oncology. 115, Supplement 1, p. S51–S52 2 p.

Population-based vs patient-specific margins for intrafractional motion in adaptive bladder radiotherapy

Caroline, G., Vestergaard, A., Høyer, M., Pedersen, E. M., Kallehauge, J. & Muren, L., Apr 2015, In: Radiotherapy & Oncology. 115, Supplementary 1, p. S226-S227 2 p.

Soft tissue vs. bony anatomy registration in an adaptive plan selection protocol for bladder cancer

Jakobsen, K. L., Petersen, J. B. B., Muren, L., Høyer, M., Lindberg, H. & Vestergaard, A., Apr 2015, In: Radiotherapy & Oncology. 115, Supplementary 1, p. S825–S826 2 p.

The potential of MRI-guided online adaptive radiotherapy of urinary bladder cancer

Vestergaard, A., Hafeez, S., Muren, L., Nill, S., Høyer, M., Vibeke Nordmark, H., Caroline, G., Pedersen, E. M., Petersen, J. B. B., Huddart, R. & Oelfke, U., Apr 2015, In: Radiotherapy & Oncology. 115, Supplementary 1, p. S194 1 p.

Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases

Fode, M. M. & Høyer, M., Feb 2015, In: Radiotherapy & Oncology. 114, 2, p. 155-60 6 p.

Survival and prognostic factors in patients treated with stereotactic radiotherapy for brain metastases

Leth, T., Oettingen, G. V., Lassen-Ramshad, Y. A., Lukacova, S. & Høyer, M., Jan 2015, In: Acta Oncologica. 54, 1, p. 107-14 8 p.

Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience

Lindberg, K., Nyman, J., Riesenfeld Källskog, V., Hoyer, M., Lund, J. Å., Lax, I., Wersäll, P., Karlsson, K., Friesland, S. & Lewensohn, R., 2015, In: Acta Oncologica. 54, 8, p. 1096-104 9 p.

Relationships between dose to the gastro-intestinal tract and patient-reported symptom domains after radiotherapy for localized prostate cancer

Thor, M., Olsson, C. E., Oh, J. H., Petersen, S. E., Alsadius, D., Bentzen, L., Pettersson, N., Muren, L. P., Waldenström, A-C., Høyer, M., Steineck, G. & Deasy, J. O., 2015, In: Acta Oncologica. 54, 9, p. 1326-34 9 p.

Fast motion-including dose error reconstruction for VMAT with and without MLC tracking

Ravkilde, T., Keall, P. J., Grau, C., Høyer, M. & Poulsen, P. R., 7 Dec 2014, In: Physics in Medicine and Biology. 59, 23, p. 7279-7296 18 p.

An adaptive radiotherapy planning strategy for bladder cancer using deformation vector fields

Vestergaard, A., Kallehauge, J. F., Petersen, J. B. B., Høyer, M., Søndergaard, J. & Muren, L. P., Sept 2014, In: Radiotherapy & Oncology. 112, 3, p. 371-5 5 p.

Normal tissue sparing in a phase II trial on daily adaptive plan selection in radiotherapy for urinary bladder cancer

Vestergaard, A., Muren, L. P., Lindberg, H., Jakobsen, K. L., Petersen, J. B. B., Elstrøm, U. V., Agerbæk, M. & Høyer, M., Aug 2014, In: Acta Oncologica. 53, 8, p. 997-1004 8 p.

Influence of image slice thickness on rectal dose-response relationships following radiotherapy of prostate cancer

Olsson, C., Thor, M., Liu, M., Moissenko, V., Petersen, S. E., Høyer, M., Apte, A. & Deasy, J. O., 21 Jul 2014, In: Physics in Medicine and Biology. 59, 14, p. 3749-59 11 p.

Kilovoltage intrafraction motion monitoring and target dose reconstruction for stereotactic volumetric modulated arc therapy of tumors in the liver

Poulsen, P. R., Worm, E. S., Petersen, J. B. B., Grau, C., Fledelius, W. & Høyer, M., 2 Jul 2014, In: Radiotherapy & Oncology.

Real-time segmentation of multiple implanted cylindrical liver markers in kilovoltage and megavoltage x-ray images

Fledelius, W., Worm, E. S., Høyer, M., Grau, C. & Poulsen, P. R., 7 Jun 2014, In: Physics in Medicine and Biology. 59, 11, p. 2787-2800 14 p.

Development and validation of a scoring system for late anorectal side-effects in patients treated with radiotherapy for prostate cancer

Petersen, S. E., Bentzen, L., Emmertsen, K. J., Laurberg, S., Lundby, L. & Høyer, M., 11 Mar 2014, In: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinical experience with adaptive radiotherapy for muscle invasive bladder cancer

Vestergaard, A., Muren, L., Høyer, M., Petersen, J. B. B., Søndergaard, J. & Elstrøm, U. V., Feb 2014, In: Radiotherapy & Oncology. 110, Supplement 1, p. S102-S103 2 p.

A comparison of morbidity following conformal versus intensity-modulated radiotherapy for urinary bladder cancer

Søndergaard, J., Holmberg, M., Jakobsen, A. R., Agerbæk, M., Muren, L. P. & Høyer, M., 2014, In: Acta Oncologica. 53, 10, p. 1321-8 8 p.

Clinical experience with adaptive radiotherapy for muscle invasive bladdercancer

Vestergaard, A., Høyer, M., Ellegaard, M-B. B., Søndergaard, J., Elstrøm, U. V., Petersen, J. B. B. & Muren, L., 2014.

Evaluation of an application for intensity-based deformable image registration and dose accumulation in radiotherapy

Thor, M., Andersen, E. S., Petersen, J. B. B., Sørensen, T. S., Noe, K. Ø., Tanderup, K., Bentzen, L., Elstrøm, U. V., Høyer, M. & Muren, L. P., 2014, In: Acta Oncologica. 53, 10, p. 1329-36 8 p.

Intra-fractional changes and the robustness of adaptive plan selection in radiotherapy for bladder cancer.

Vestergaard, A., Høyer, M., Alber, M., Söhn, M., Pedersen, E. M., Petersen, J. B. B. & Muren, L., 2014. 2 p.

Pathophysiology of late anorectal dysfunction following external beam radiotherapy for prostate cancer

Petersen, S. E., Bregendahl, S., Langschwager, M., Laurberg, S., Brock, C., Drewes, A. M., Krogh, K., Høyer, M. & Lundby, L., 2014, In: Acta Oncologica. 53, 10, p. 1398-404 7 p.

Quality of venous thromboembolism diagnoses among prostate cancer patients in the Danish National Registry of Patients

Drljevic, A., Borre, M., Høyer, M., Ehrenstein, V. & Nguyen-Nielsen, M., 2014, In: Clinical epidemiology. 6, p. 351-7 7 p.

Time-resolved dose distributions to moving targets during volumetric modulated arc therapy with and without dynamic MLC tracking

Ravkilde, T., Keall, P. J., Grau, C., Høyer, M. & Poulsen, P. R., Nov 2013, In: Medical Physics. 40, 11, 111723.

Biology-guided adaptive radiotherapy (BiGART) - more than a vision?

Grau, C., Høyer, M., Alber, M., Overgaard, J., Lindegaard, J. C. & Muren, L. P., Oct 2013, In: Acta Oncologica. 52, 7, p. 1243-7 5 p.

Variations in magnitude and directionality of respiratory target motion throughout full treatment courses of stereotactic body radiotherapy for tumors in the liver

Worm, E. S., Høyer, M., Fledelius, W., Hansen, A. T. & Poulsen, P. R., Oct 2013, In: Acta Oncologica. 52, 7, p. 1437-1444 8 p.

Three-dimensional, Time-Resolved, Intrafraction Motion Monitoring Throughout Stereotactic Liver Radiation Therapy on a Conventional Linear Accelerator

Worm, E. S., Høyer, M., Fledelius, W. & Poulsen, P. R., 1 May 2013, In: International Journal of Radiation Oncology, Biology, Physics. 86, 1, p. 190-197 8 p.

Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets

Thörnqvist, S., Muren, L. P., Bentzen, L., Hysing, L. B., Høyer, M., Grau, C. & Petersen, J. B. B., Apr 2013, In: Acta Oncologica. 52, 3, p. 521-527 7 p.

Adaptive plan selection vs. re-optimisation in radiotherapy for bladder cancer: A dose accumulation comparison

Vestergaard, A., Muren, L. P., Søndergaard, J., Elstrøm, U. V., Høyer, M. & Petersen, J. B., 2013, In: Radiotherapy & Oncology. 109, 3, p. 457-62 6 p.

Time-resolved dose reconstruction by motion encoding of volumetric modulated arc therapy fields delivered with and without dynamic multi-leaf collimator tracking

Ravkilde, T., Keall, P. J., Grau, C., Høyer, M. & Poulsen, P. R., 2013, In: Acta Oncologica. 52, 7, p. 1497-1503 9 p.

Validity of the Danish National Registry of Patients for chemotherapy reporting among colorectal cancer patients is high

Lund, J. L., Frøslev, T., Deleuran, T., Erichsen, R., Nilsson, T., Pedersen, A. N. & Høyer, M., 2013, In: Clinical epidemiology. 5, 1, p. 327-34 8 p.

Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma

Jensen, T. Ø., Schmidt, H., Møller, H. J., Donskov, F., Høyer, M., Sjoegren, P., Christensen, I. J. & Steiniche, T., 1 May 2012, In: Cancer. 118, 9, p. 2476-2485

An international survey on liver metastases radiotherapy

Lock, M. I., Høyer, M., Bydder, S. A., Okunieff, P., Hahn, C. A., Vichare, A. & Dawson, L. A., 2012, In: Acta Oncologica. 51, 5, p. 568-74 7 p.

Biomechanical deformable registration based dose accumulation vs. dose summation for the bladder

Andersen, E. S., Muren, L., Sørensen, T. S., Noe, K. Ø., Thor, M., Petersen, J. B. B., Høyer, M., Bentzen, L. N. & Tanderup, K., 2012, In: Radiotherapy & Oncology. 103, Supplement 1

Bladder dose accumulation based on a biomechanical deformable image registration algorithm in volumetric modulated arc therapy for prostate cancer

Andersen, E., Muren, L., Sørensen, T. S., Noe, K. Ø., Thor, M., Petersen, J. B. B., Høyer, M., Bentzen, L. N. & Tanderup, K., 2012, In: Physics in Medicine and Biology. 57, 21, p. 7089-7100 12 p.

DaProCadata - Dansk Prostatacancer Database

Borre, M., Høyer, M., Friis, S., Hansen, S., Brasso, K., Petersen, A., Nørgaard, M., Olsen, M. S. & Bartels, P., 2012, In: Ugeskrift for Laeger. 174, 42, p. 2556 1 p.

Deformable image registration for contour propagation in the pelvis based on two different CBCT reconstructions

Thor, M., Elstrøm, U. V., Petersen, J. B. B., Bentzen, L. N., Høyer, M. & Muren, L., 2012, In: Radiotherapy & Oncology. 103, Supplement 1, p. 536 1 p.

Evaluation of a pre-release dose accumulation software based on deformable image registration applied to the bladder

Thor, M., Petersen, J. B. B., Elstrøm, U. V., Andersen, E. S., Tanderup, K., Sørensen, T. S., Noe, K. Ø., Bentzen, L. N., Høyer, M. & Muren, L., 2012, In: Radiotherapy & Oncology. 103, Supplement 1, p. 139 1 p.

On-line use of three-dimensional marker trajectory estimation from cone-beam computed tomography projections for precise setup in radiotherapy for targets with respiratory motion

Worm, E. S., Høyer, M., Fledelius, W., Nielsen, J. E., Larsen, L. P. & Poulsen, P. R., 2012, In: International Journal of Radiation Oncology, Biology, Physics. 83, 1, p. e145-51

Radiation therapy for liver metastases

Mendez Romero, A. & Høyer, M., 2012, In: Current Opinion in Supportive and Palliative Care. 6, 1, p. 97-102 6 p.

Radiotherapy for liver metastases: A review of evidence

Høyer, M., Swaminath, A., Bydder, S., Lock, M., Méndez Romero, A., Kavanagh, B., Goodman, K. A., Okunieff, P. & Dawson, L. A., 2012, In: International Journal of Radiation Oncology, Biology, Physics. 82, 3, p. 1047-57 11 p.

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy: A national Danish study

Ervandian, M. S., Høyer, M. & Borre, M., 2012.

Stereotactic body radiation therapy-a discipline with Nordic origin and profile

Muren, L. P. & Høyer, M., 2012, In: Acta Oncologica. 51, 5, p. 564-567 4 p.

TIME-RESOLVED EVOLVEMENT OF TARGET DOSE DISTRIBUTION DURING IMAT WITH AND WITHOUT DYNAMIC MLC TRACKING

Ravkilde, T. L., Keall, P. J., Grau, C., Høyer, M. & Poulsen, P. R., 2012, In: Radiotherapy & Oncology. 103, Supplement 1, p. 137 1 p.

Advances in radiotherapy: from 2D to 4D

Høyer, M., Thor, M., Thörnqvist, S., Søndergaard, J., Lassen-Ramshad, Y. & Muren, L., 3 Oct 2011, In: Cancer Imaging. 11, A, p. S147-S152 6 p.

Deformable image registration for contour propagation from CT to cone-beam CT scans in radiotherapy of prostate cancer

Thor, M., Petersen, J. B. B., Bentzen, L., Høyer, M. & Muren, L. P., 1 Aug 2011, In: Acta Oncologica. 50, 6, p. 918-925 8 p.

Clinical validation of a 4D-CT based method for lung ventilation measurement in phantoms and patients

Nyeng, T. B., Kallehauge, J. F., Høyer, M., Petersen, J. B. B., Poulsen, P. R. & Muren, L. P., Aug 2011, In: Acta Oncologica. 50, 6, p. 897-907 11 p.

Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours

Petersen, J. B. B., Lassen, Y., Hansen, A. T., Muren, L. P., Grau, C. & Høyer, M., Aug 2011, In: Acta Oncologica. 50, 6, p. 823-828 6 p.

NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction

Wennberg, B. M., Baumann, P., Gagliardi, G., Nyman, J., Drugge, N., Høyer, M., Hansen, A. T., Nilsson, K., Morhed, E., Ekberg, L., Wittgren, L., Lund, J-Å., Levin, N., Sederholm, C., Lewensohn, R. & Lax, I., May 2011, In: Acta Oncologica.

Faecal incontinence following radiotherapy for prostate cancer: A systematic review

Maeda, Y., Høyer, M., Lundby, L. & Norton, C., Feb 2011, In: Radiotherapy & Oncology. 98, 2, p. 145-53 9 p.

Survival in patients with synchronous liver metastases in central and northern Denmark, 1998 to 2009

Høyer, M., Erichsen, R., Gandrup, P., Nørgaard, M. & Jacobsen, J. B., 1 Jan 2011, In: Clinical Epidemiology. 3 Suppl 1, p. 11-7 7 p.

Survival of patients with primary liver cancer in central and northern Denmark, 1998-2009

Montomoli, J., Erichsen, R., Nørgaard, M., Høyer, M., Hansen, J. B. & Jacobsen, J. B., 1 Jan 2011, In: Clinical Epidemiology. 3 Suppl 1, p. 3-10 8 p.

Particle therapy - a next logical step in the improvement of radiotherapy

Nyström, H., Blomqvist, E., Høyer, M., Montelius, A., Muren, L. P., Nilsson, P., Taheri-Kadkhoda, Z. & Glimelius, B., 2011, In: Acta Oncologica. 50, 6, p. 741-4 4 p.

Plan robustness in proton beam therapy of a childhood brain tumour

Lassen-Ramshad, Y., Vestergaard, A., Muren, L. P., Høyer, M. & Petersen, J. B. B., 2011, In: Acta Oncologica. 50, 6, p. 791-796 6 p.

Robust automatic segmentation of multiple implanted cylindrical gold fiducial markers in cone-beam CT projections

Fledelius, W., Worm, E. S., Elstrøm, U. V., Petersen, J. B. B., Grau, C., Høyer, M. & Poulsen, P. R., 2011, In: Medical Physics. 38, 12, p. 6351

A comparison of three different adaptive strategies in image-guided radiotherapy of bladder cancer

Vestergaard, A., Søndergaard, J., Petersen, J. B., Høyer, M. & Muren, L. P., 1 Oct 2010, In: Acta Oncologica. 49, 7, p. 1069-1076 8 p.

A study of image-guided radiotherapy of bladder cancer based on lipiodol injection in the bladder wall

Søndergaard, J., Olsen, K. Ø., Muren, L., Elstrøm, U. V., Grau, C. & Høyer, M., 1 Oct 2010, In: Acta Oncologica. 49, 7, p. 1109-1115 7 p.

Biology-guided adaptive radiation therapy - presence or future?

Grau, C., Olsen, D. R., Overgaard, J., Høyer, M., Lindegaard, J. C. & Muren, L., 1 Oct 2010, In: Acta Oncologica. 49, 7, p. 884-887 4 p.

Evaluation of adaptive radiotherapy of bladder cancer by image-based tumour control probability modelling

Wright, P., Muren, L., Høyer, M. & Malinen, E., 1 Oct 2010, In: Acta Oncologica. 49, 7, p. 1045-1051 7 p.

Imaging of normal lung, liver and parotid gland function for radiotherapy

Partridge, M., Yamamoto, T., Grau, C., Høyer, M. & Muren, L., 1 Oct 2010, In: Acta Oncologica. 49, 7, p. 997-1011 15 p.

Inter- and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and lung

Worm, E. S., Hansen, A. T., Petersen, J. B. B., Muren, L. P., Præstegaard, L. H. P. & Høyer, M., 1 Oct 2010, In: Acta Oncologica. 49, 7, p. 1177-1183 7 p.

Propagation of target and organ at risk contours in radiotherapy of prostate cancer using deformable image registration

Thörnqvist, S., Petersen, J. B. B., Høyer, M., Bentzen, L. N. & Muren, L., 1 Oct 2010, In: Acta Oncologica. 49, 7, p. 1023-1032 10 p.

Temporary sacral nerve stimulation for faecal incontinence following pelvic radiotherapy

Maeda, Y., Høyer, M., Lundby, L., Buntzen, S. & Laurberg, S., 1 Oct 2010, In: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 97, 1, p. 108-12 5 p.

Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer

Buch-Hansen, T. Z., Bentzen, L. N., Hansen, S., Høyer, M., Jensen, N. V., Saxe, C. & Sengeloev, L., 1 Jul 2010, In: Cancer Chemotherapy and Pharmacology. 66, 2, p. 295-301 7 p.

Stereotactic body radiotherapy for unresectable cholangiocarcinoma

Kopek, N., Holt, M. I., Hansen, A. T. & Høyer, M., Jan 2010, In: Radiotherapy & Oncology. 94, 1, p. 47-52 5 p.

Temporary sacral nerve stimulation for faecal incontinence following pelvic radiotherapy

Maeda, Y., Høyer, M., Lundby, L., Buntzen, S. & Laurberg, S., 2010, In: Radiotherapy & Oncology. 97, p. 108-112 5 p.

Temporary sacral nerve stimulation for faecal incontinence following pelvic radiotherapy

Maeda, Y., Høyer, M., Lundby, L., Buntzen, S. & Laurberg, S., 2010, In: Radiotherapy & Oncology. S1, p. s368-9 1 p.

Temporary sacral nerve stimulation is a successful treatment for fecal incontinence caused by pelvic radiotherapy

Maeda, Y., Høyer, M., Lundby, L., Buntzen, S. & Laurberg, S., 2010.

A method to individualize adaptive planning target volumes for deformable targets

Wright, P., Redpath, A. T., Høyer, M. & Muren, L., 7 Dec 2009, In: Physics in Medicine and Biology. 54, 23, p. 7121-7133 12 p.

Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer

Kopek, N., Paludan, M., Petersen, J., Hansen, A. T., Grau, C. & Høyer, M., Dec 2009, In: Radiotherapy & Oncology. 93, 3, p. 402-407 5 p.

Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma

Jensen, T. O., Schmidt, H., Møller, H. J., Høyer, M., Maniecki, M. B., Sjøgren, P., Christensen, I. J. & Steiniche, T., 10 Jul 2009, In: Journal of Clinical Oncology. 27, 20, p. 3330-3337 8 p.

Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy

Baumann, P., Nyman, J., Høyer, M., Wennberg, B., Gagliardi, G., Lax, I., Drugge, N., Ekberg, L., Friesland, S., Johansson, K-A., Lund, J-A., Morhed, E., Nilsson, K., Levin, N., Paludan, M., Sederholm, C., Hansen, A. T., Wittgren, L. & Lewensohn, R., 10 Jul 2009, In: Journal of Clinical Oncology. 27, 20, p. 3290-6 6 p.

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

Widmark, A., Klepp, O., Solberg, A., Damber, J-E., Angelsen, A., Fransson, P., Lund, J-A., Tasdemir, I., Høyer, M., Wiklund, F. & Fosså, S. D., Jan 2009, In: Lancet. 373, 9660, p. 301-8 8 p.

Half body irradiation of patients with multiple bone metastases: A phase II trial

Berg, R., Yilmaz, M., Høyer, M., Keldsen, N., Nielsen, O. & Ewertz, M., 2009, In: Acta Oncologica. 48, 4, p. 556-561 6 p.

Macrophage Markers in Serum and Tumor Have Prognostic Impact in American Joint Committee on Cancer Stage I/II Melanoma

Jensen, T. Ø., Schmidt, H., Møller, H. J., Høyer, M., Maniecki, M. B., Sjoegren, P., Christensen, I. J. & Steiniche, T., 2009, In: Journal of Clinical Oncology. 27, 20, p. 3330-3337 7 p.

The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy

Søndergaard, J., Høyer, M., Petersen, J. B., Wright, P., Grau, C. & Muren, L., 2009, In: Acta Oncologica. 48, 2, p. 238-244 6 p.

Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study

Baumann, P., Nyman, J., Høyer, M., Gagliardi, G., Lax, I., Wennberg, B., Drugge, N., Ekberg, L., Friesland, S., Johansson, K-A., Lund, J-S., Morhed, E., Nilsson, K. K., Levin, N., Paludan, M., Sederholm, C., Hansen, A. T., Wittgren, L. & Lewensohn, R., 1 Sept 2008, In: Radiotherapy & Oncology. 88, 3, p. 359-367 9 p.

Improved accuracy and outcome in radiotherapy of lung cancer

Høyer, M., Apr 2008, In: Radiotherapy & Oncology. 87, 1, p. 1-2 2 p.

Image-guided adaptive radiotherapy - integration of biology and technology to improve clinical outcome

Grau, C., Muren, L., Høyer, M., Lindegaard, J. & Overgaard, J., 2008, In: Acta Oncologica. 47, 7, p. 1182-1185 4 p.

Intrafraction changes of prostate position and geometrical errors studied by continuous electronic portal imaging

Månsson Haskå, T., Honoré, H. H., Muren, L., Høyer, M. & Poulsen, P. R., 2008, In: Acta Oncologica. 47, 7, p. 1351-1357 6 p.

Positronemissionstomografi har klinisk betydning ved planlaegning af behandling af kolorektale levermetastaser. Sekundaerpublikation.

Sørensen, M., Mortensen, F. V., Høyer, M., Vilstrup, H. & Keiding, S., 2008, In: Ugeskrift for Laeger. 170, 16, p. 1364-6 2 p.

The normal tissue sparing potential of adaptive strategies in radiotherapy of bladder cancer

Wright, P., Redpath, A. T., Høyer, M., Grau, C. & Muren, L., 2008, In: Acta Oncologica. 47, 7, p. 1382-1389 7 p.

The prognostic role of protumoral macrophages in AJCC stage I/II melanoma

Jensen, T. Ø., Høyer, M., Schmidt, H., Møller, H. J. & Steiniche, T., 2008.

Residual set-up errors and margins in on-line image-guided prostate localization in radiotherapy

Poulsen, P. R., Muren, L. & Høyer, M., Nov 2007, In: Radiotherapy & Oncology. 85, 2, p. 201-206 6 p.

Accuracy of image-guided radiotherapy of prostate cancer based on the BeamCath urethral catheter technique.

Poulsen, P. R., Fokdal, L., Petersen, J. B. B. & Høyer, M., Apr 2007, In: Radiotherapy & Oncology. 83, 1, p. 25-30 5 p.

Baggrund for information om kurativ intenderet behandling af prostatacancer.

Borre, M. & Høyer, M., 2007, Notat af 30.06.2007 ed. Uro-onkologisk Forum.

Behandling af hormonrefraktær prostatacancer

Høyer, M., 2007, In: NUF-bulletin.

Behandling af lokaliseret prostatacancer.

Jakobsen, H., Iversen, P., Mikines, K. J., Nørgaard, N. & Høyer, M., 2007, In: Ugeskrift for Laeger. 169, 20, p. 1902-4 2 p.

FDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: a consecutive prospective study

Sørensen, M., Mortensen, F. V., Høyer, M., Vilstrup, H., Keiding, S. & Liver Tumour Board at Aarhus University Hospital, 2007, In: Scandinavian Journal of Surgery. 96, 3, p. 209-213 5 p.

Accuracy of Prostate Localization using Implanted Gold Markers and Varian's On-Board Image System

Poulsen, P. R., Honoré, H. H. & Høyer, M., Oct 2006, Ikke angivet. Suppl 1 ed. Radiother Oncol, p. 145

Radical radiotherapy for urinary bladder cancer: treatment outcomes

Fokdal, L., Høyer, M., von der Maase, H. & Høyer, M., Feb 2006, In: Expert Review of Anticancer Therapy. 6, 2, p. 269-79 11 p.

Radical radiotherapy for urinary bladder cancer: treatment outcomes

Fokdal, L., Høyer, M. & Maase, H. V. D., Feb 2006, In: Expert Review of Anticancer Therapy. 6, 2, p. 269-279 11 p.

Phase II study on stereotactic body radiotherapy of colorectal metastases

Høyer, M., Roed, H., Traberg Hansen, A., Ohlhuis, L., Petersen, J., Nellemann, H., Berthelsen, A. K., Grau, C., Engelholm, S. A. & Von der Maase, H., 1 Jan 2006, In: Acta Oncologica. 45, 7, p. 823-30 8 p.

The emerging evidence for Stereotactic Body Radiotherapy

Grau, C., Høyer, M., Lindegaard, J. C. & Overgaard, J., 1 Jan 2006, In: Acta Oncologica. 45, 7, p. 771-774 4 p.

Acute Pulmonary Morbidity following Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer

Paludan, M., Hansen, A. T., Petersen, J. B. B., Grau, C. & Høyer, M., 2006.

A Danish Phase II Trial on Stereotactic Body Radiotherapy for Colo-rectal Metastases

Høyer, M., Roed, H., Hansen, A. T., Ohlhuis, L., Petersen, J. B. B., Nellemann, H. M., Bertelsen, A. K., Grau, C., Engelholm, S. A. & Maase, H. V. D., 2006.

Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?

Paludan, M., Hansen, A. T., Petersen, J. B. B., Grau, C. & Høyer, M., 2006, In: Acta Oncologica. 45, 7, p. 818-822 5 p.

Dummy run for a phase II study of stereotactic body radiotherapy of T1-T2      N0M0 medical inoperable non-small cell lung cancer

Djärv, E., Nyman, J., Baumann, P., Ekberg, L., Høyer, M., Lax, I., Lewensohn, R., Levin, N., Lund, J-Å., Morhed, E., Ericsson, S. R., Hansen, A. T., Wittgren, L. & Johansson, K-A., 2006, In: Acta Oncologica. 45, 7, p. 973-977 5 p.

Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries

Baumann, P., Nyman, J., Lax, I., Friesland, S., Høyer, M., Rehn Ericsson, S., Johansson, K-A., Ekberg, L., Morhed, E., Paludan, M., Wittgren, L., Blomgren, H. & Lewensohn, R., 2006, In: Acta Oncologica. 45, 7, p. 787-795 9 p.

Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.

Baumann, P., Nyman, J., Lax, I., Friesland, S., Høyer, M., Ericsson, S. R., Johansson, K-A., Ekberg, L., Morhed, E., Paludan, M., Wittgren, L., Blomgren, H. & Lewensohn, R., 2006, In: Acta Oncologica. 45, 7, p. 787-795 9 p.

Højpræcisions konform strålebehandling

Grau, C. & Høyer, M., 2006, In: Månedsskr. prakt. lægegerning. 84, p. 291-296 6 p.

Internal Movement, Set-Up Accuracy and Margins for Stereotactic Body Radiotherapy Using a Stereotactic Body Frame

Hansen, A. T., Petersen, J. B. B. & Høyer, M., 2006, In: Acta Oncologica. 45, 7, p. 948-952 5 p.

Intra- and Interfractional Movements of the BeamCath Urethral Catheter for Image-Guided Radiotherapy of Prostatae Cancer

Honoré, H. H., Poulsen, P. R. & Høyer, M., 2006, Ikke angivet. Suppl 1 ed. Radiother Oncol, Vol. 81. p. 223

Onkologisk behandling af prostatacancer

Høyer, M., 2006, In: Månedsskr. prakt. lægegerning.

Phase II study on stereotactic body radiotherapy of colorectal metastases

Høyer, M., Roed, H., Hansen, A. T., Ohlhuis, L., Petersen, J. B. B., Nellemann, H. M., Berthelsen, A. K., Grau, C., Engelholm, S. A. & Maase, H. V. D., 2006, In: Acta. Oncol.. 45, p. 823-830 8 p.

Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer

Høyer, M., Roed, H., Hansen, A. T., Ohlhuis, L., Petersen, J. B. B., Nellemann, H. M., Berthelsen, A. K., Grau, C., Engelholm, S. A. & Maase, H. V. D., 2006, In: International Journal of Radiation Oncology, Biology, Physics. 66/4, p. S128-135 8 p.

Stereotaktisk strålebehandling af hjernetumorer

Høyer, M., Roed, H. & Schultz, H. P., 2006, In: Månedsskr for prak lægegerning. april/4, p. 381-390 10 p.

Comparison of Two Dose Calculation Methods Applied to Extracranial Stereotactic Radiotheraphy Treatment Planning

Hansen, A. T., Petersen, J. B. B., Høyer, M. & Christensen, J. J., Oct 2005, In: Radiotherapy & Oncology. 77, 1, p. 96-98 3 p.

Senbivirkninger efter kurativ strålebehandling for cancer prostatae

Fokdal, L. U., Høyer, M. & Høyer, M., 12 Sept 2005, In: Ugeskrift for Laeger. 167, 37, p. 3502-7 6 p.

Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy

Fokdal, L., Honoré, H., Høyer, M., von der Maase, H. & Høyer, M., Feb 2005, In: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 74, 2, p. 203-10 8 p.

Dose-volume Histograms Associated to Long-term Colorectal Functions in Patients Receiving Pelvic Radiotherapy

LU, F., Honoré, H. H., Høyer, M. & Maase, H. V. D., Feb 2005, In: Radiotherapy & Oncology. 74, 2, p. 203-210 8 p.

Comparison of two dose calculation methods applied to extracranial stereotactic radiotherapy treatment planning

Traberg Hansen, A., Petersen, J. B., Høyer, M., Christensen, J. J. & Høyer, M., 2005, In: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 77, 1, p. 96-8 3 p.

High-precision radiotherapy

Grau, C. & Høyer, M., 2005, In: European Oncology Review. p. 40-44 5 p.

Ny teknologi giver mere præcis strålebehandling af kræft

Grau, C., Høyer, M. & Schultz, H. P., 2005, In: Medicus. 2, p. 5-12 8 p.

Onkologisk behandling af meningeal carcinomatose

Sulim, S. & Høyer, M., 2005, In: Ugeskrift for Laeger. 167, p. 3481-3485 5 p.

Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma

Høyer, M., Roed, H., Sengeløv, L., Hansen, A. T., Ohlhuis, L., Petersen, J. B. B., Nellemann, H. M., Berthelsen, A. K., Eberholst, F., Engelholm, S. A. & Maase, H. V. D., 2005, In: Radiother. Oncol.. 76, 1, p. 48-53 6 p.

Senbivirkninger efter kurativt anlagt strålebehandling for prostata cancer

Fokdal, L. & Høyer, M., 2005, In: Ugeskrift for Laeger. 167, 37, p. 3502-3507 6 p.

Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer

LU, F., Høyer, M., Meldgaard, P. & Maase, H. V. D., Aug 2004, In: Radiotherapy & Oncology. 72, 2, p. 139-145 7 p.

Impact of Changes in Bladder and Rectal Filling Volume on Organ Motion and Dose Distribution of the Bladder for Radiotherapy of Urinary Bladder Cancer

Fokdal, L., Honoré, H. H., Høyer, M., Meldgaard, P., Fode, K. & Maase, H. V. D., 1 Jun 2004, In: International Journal of Radiation Oncology, Biology, Physics. 59, 2, p. 436-444 9 p.

Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer

Fokdal, L., Honoré, H., Høyer, M., Meldgaard, P., Fode, K., von der Maase, H. & Høyer, M., 1 Jun 2004, In: International Journal of Radiation Oncology, Biology, Physics. 59, 2, p. 436-44 9 p.

Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer

Fokdal, L., Høyer, M. & Maase, H. V. D., 2004, In: Acta Oncologica. 43, 8, p. 749-757 9 p.

Implementation of intensity modulated radiotheraphy in Aarhus, Denmark

Petersen, J. B. B., Spejlborg, H., Hansen, A. T., Thomsen, M. S., Tanderup, K., Vestergaard, A., Høyer, M., Lindegaard, J. C., Ulsø, N. & Grau, C., 2002, In: Radiother. Oncol.. 64, p. 216-216 1 p.

Phase II study of vinorelbine in the treatment of platinum-resistant ovarian carcinoma

Sørensen, P., Høyer, M., Jakobsen, A., Malmström, H., Havsteen, H. & Bertelsen, K., Apr 2001, In: Gynecologic Oncology. 81, 1, p. 58-62 5 p.

Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck

Alsner, J., Høyer, M., Sørensen, S. B. & Overgaard, J., 1 Feb 2001, In: International Journal of Radiation Oncology, Biology, Physics. 49, 2, p. 519-525 7 p.

Dynamic cell cycle kinetics in vitro and in vivo in myelodysplastic syndromes with special reference to the influence of hematopoietic growth factors

Holm, M. S., Høyer, M., Jensen, I., Thomsen, M. & Hokland, P., Dec 2000, In: Leukemia Research. 24, 12, p. 999-1008 10 p.

The effect of castration on tumour growth rate and cell kinetics in hormone-sensitive and hormone-insensitive rat prostatic adenomas

Nerstrøm Salling, L., Høyer, M. & Overgaard, J., Nov 1999, In: Urologic Oncology: Seminars and Original Investigations. 2, S3, p. S29 1 p.

Dynamic cell cycle kinetics of normal CD34+ cells and CD38+/- subsets of haemopoietic progenitor cells in G-CSF-mobilized peripheral blood

Holm, M., Thomsen, M., Høyer, M. & Hokland, P., Jun 1999, In: British Journal of Haematology. 105, 4, p. 1002-1013 12 p.

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis

Begg, A. C., Haustermans, K., Hart, A. A., Dische, S., Saunders, M., Zackrisson, B., Gustaffson, H., Coucke, P., Paschoud, N., Høyer, M., Overgaard, J., Antognoni, P., Richetti, A., Bourhis, J., Bartelink, H., Horiot, J. C., Corvo, R., Giaretti, W., Awwad, H., Shouman, T., & 5 othersJouffroy, T., Maciorowski, Z., Dobrowsky, W., Struikmans, H. & Wilson, G. D., Jan 1999, In: Radiotherapy & Oncology. 50, 1, p. 13-23 11 p.

Ekstracerebral stereotaktisk strålebehandling--et nyt behandlingsprincip

von der Maase, H., Høyer, M. & Høyer, M., 1999, In: Ugeskrift for Laeger. 161, 20, p. 2957

DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cure

Borre, M., Høyer, M., Nerstrøm, B. & Overgaard, J., 1 Sept 1998, In: Prostate. 36, 4, p. 244-249 6 p.

Hypoxia in human soft tissue sarcomas is associated with poor survival.

Nordsmark, M., Keller, J. Ø., Høyer, M., Nielsen, O. S., Jensen, O. M. & Overgaard, J., Sept 1998, In: Radiotherapy & Oncology.

Optimization of a flow cytometric method for the simultaneous measurement of cell surface antigen, DNA content, and in vitro BrdUrd incorporation into normal and malignant hematopoietic cells

Holm, M. S., Thomsen, M., Høyer, M. & Hokland, P., 1 May 1998, In: Cytometry. 32, 1, p. 28-36 9 p.

Association between in vivo iododeoxyuridine labeling, MIB-1 expression, malignancy grade and clinical stage in human prostate cancer

Borre, M., Høyer, M., Sørensen, F. B., Nerstrøm, B. & Overgaard, J., Mar 1998, In: A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica. 106, 3, p. 389-395 7 p.

Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck

Høyer, M., Jørgensen, K., Bundgaard, T., Johansen, L. V., Bentzen, S. M., Overgaard, M., Hansen, O., Søgaard, H. & Overgaard, J., Feb 1998, In: Radiotherapy & Oncology. 46, 2, p. 147-155 9 p.

Association between in vivo iododeoxyuridine labelling, MIB-1 expression, malignancy grade and clinical stage in human prostate cancer

Borre, M., Høyer, M., Sørensen, F. B., Nerstrøm, B. & Overgaard, J., 1998, In: Acta Pathologica Microbiologica et Immunologica Scandinavica. 106, p. 389-95

Deoxyribonucleic acid ploidy and survival in clinically localized prostate cancer patients treated without intent to cure

Borre, M., Høyer, M., Nerstrøm, B. & Overgaard, J., 1998, In: Prostate. 36, p. 244-9

Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation

Hansen, O., Overgaard, J., Hansen, H. S., Overgaard, M., Høyer, M., Jørgensen, K. E., Bastholt, L. & Berthelsen, A., Apr 1997, In: Radiotherapy & Oncology. 43, 1, p. 47-51 5 p.

Oxygenation stage cell kinetics and 31p MR spectroscopy in human soft tissue sarcomas.

Norsmark, M., Høyer, M., Keller, J. Ø., Nielsen, O. S., Maxwell, R., Lunddorf, E., Jensen, O. M. & Overgaard, J., Sept 1996, In: Radiotherapy & Oncology.

The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas.

Nordsmark, M., Høyer, M., Keller, J. Ø., Nielsen, O. S., Jensen, O. M. & Overgaard, J., 1 Jul 1996, In: International Journal of Radiation Oncology, Biology, Physics. 35, 4, p. 701-708 8 p.

MIB-1 expression and iododeoxyuridine labelling in soft tissue sarcomas: an immunohistochemical study including correlations with p53, bcl-2 and histological characteristics

Jensen, V., Høyer, M., Sørensen, F. B., Keller, J. Ø. & Jensen, O. M., May 1996, In: Histopathology. 28, 5, p. 437-444 8 p.

Oxygenation and cell kinetics in soft tissue sarcoma treated by adjuvant radiation therapy.

Norsmark, M., Høyer, M., Keller, J. Ø., Nielsen, O. S., Jensen, O. M. & Overgaard, J., Mar 1996.

Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumours

Horsman, M. R., Nordsmark, M., Høyer, M. & Overgaard, J., Dec 1995, In: B J C. 72, 6, p. 1474-1478 5 p.

Oxygenation and cell kinetics in soft tissue sarcoma treated by adjuvant radiation therapy.

Keller, J. Ø., Nordsmark, M., Høyer, M., Nielsen, O. S., Myhre Jensen, O., Sneppen, O. & Overgaard, J., May 1995.

The effect of castration on tumor growth rate and cell kinetics in hormone sensitive and hormone insensitive rat prostatic adenocarcinomas

Salling, L. N., Høyer, M. & Overgaard, J., 1995, In: Scandinavian Journal of Urology and Nephrology. Supplement. 172, p. 73-79 7 p.

The in vivo interaction between vincristine and radiation in a C3H mammary carcinoma and the feet of CDF1 mice

Grau, C., Høyer, M. & Overgaard, J., 1 Dec 1994, In: International Journal of Radiation Oncology, Biology, Physics. 30, 5, p. 1141-1146 6 p.

Correlation between oxygenation status and cell kinetics in human soft tissue sarcoma.

Nordsmark, M., Høyer, M., Keller, J. Ø., Nielsen, O. S., Jensen, O. M. & Overgaard, J., Sept 1994, In: Radiotherapy & Oncology.

Influence of sampling time on assessment of potential doubling time

Høyer, M., Bentzen, S. M., Salling, L. N. & Overgaard, J., 1 Jun 1994, In: Cytometry. 16, 2, p. 144-151 8 p.

A Flow cytometric Model for Determination of Tumour Cell Kinetics

Høyer, M., 1994

Nicotinamide pharmacokinetics in humans and mice: A comparative assessment and the implications for radiotherapy

Horsman, M. R., Høyer, M., Honess, D. J., Dennis, I. F. & Overgaard, J., May 1993, In: Radiotherapy & Oncology. 27, 2, p. 131-139 9 p.

Influence of dose on regeneration of murine hematopoietic stem cells after total body irradiation and 5-fluorouracil

Høyer, M., Nielsen, O. S. & Høyer, M., 1992, In: Oncology. 49, 2, p. 166-72 7 p.

Regeneration of murine hematopoietic stem cells after total body irradiation and 5-fluorouracil

Høyer, M. & Nielsen, O. S., 1992, In: Oncology. 49, 2, p. 166-172 7 p.

Influence of dose on the regeneration of murine hematopoietic stem cells after total body irradiation and chemotherapeutic drugs.

Nielsen, O. S., Høyer, M. & Overgaard, J., Jul 1991.

DNA flow cytometry in uterine endometrial carcinoma

Jacobsen, M., Høyer, M., Bentzen, S. M. & Nielsen, K., 1991, In: APMIS Supplementum. 23, p. 107-112 6 p.

Radical hysterectomy in cervical carcinoma stage Ib

Høyer, M., Ljungström, B., Nyland, M. H. & Jakobsen, A., 1990, In: European Journal of Gynecological Oncology. 11, 1, p. 13-17 5 p.

Screening for hypertension af 40-64-årige maend

Jastrup, B., Faldborg, L., Hansen, T. B., Høyer, M., Lass, P. & Olesen, C., 13 Jan 1986, In: Ugeskrift for Laeger. 148, 3, p. 119-121 3 p.

Activities

Danish Multidisciplinary Uro-oncology Group (External organisation)

Morten Høyer (Member)

2001 → 2011

Danish Society of Oncology

Morten Høyer (Organizer)

2000 → …

Nordic Conference on Radiation Oncology

Morten Høyer (Organizer)

2001 → …

Scandinavian Prostatic Canser Group (External organisation)

Morten Høyer (Member)

2001 → 2011